{"pmid":32367287,"pmcid":"PMC7198092","title":"New evidence of SARS-CoV-2 transmission through the ocular surface.","text":["New evidence of SARS-CoV-2 transmission through the ocular surface.","Graefes Arch Clin Exp Ophthalmol","Qing, Huiling","Yang, Zhengwei","Shi, Menghai","Zhang, Zongduan","32367287"],"journal":"Graefes Arch Clin Exp Ophthalmol","authors":["Qing, Huiling","Yang, Zhengwei","Shi, Menghai","Zhang, Zongduan"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32367287","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s00417-020-04726-4","topics":["Transmission"],"weight":1,"_version_":1666138496249626624,"score":9.490897,"similar":[{"pmid":32289466,"pmcid":"PMC7194535","title":"The evidence of SARS-CoV-2 infection on ocular surface.","text":["The evidence of SARS-CoV-2 infection on ocular surface.","This is a cross-sectional study of patients who received a COVID-19 diagnosis between December 30, 2019 and February 7, 2020 at Tongji Hospital. A total of 102 patients (48 Male [47%] and 54 Female [53%]) with clinical symptoms, Rt, and chest Computed Tomography (CT) abnormalities were identified with a clinical diagnosis of COVID-19. Patients had a mean [SD] gestational age of 57.63 [14.90] years. Of a total of 102 patients identified, 72 patients (36 men [50%] and 36 women [50%]; mean [SD] age, 58.68 [14.81] years) were confirmed to have COVID-19 by laboratory diagnosis with a SARS-CoV-2 RT-PCR assay. Only two patients (2.78%) with conjunctivitis were identified from 72 patients with a laboratory confirmed COVID-19. Of those two patients, SARS-CoV-2 RNA fragments were found in ocular discharges by SARS-CoV-2 RT-PCR in only one patient. Our findings suspect the incidence of SARS-CoV-2 infection through the ocular surface is extremely low, while the nosocomial infection of SARS-CoV-2 through the eyes after occupational exposure is a potential route. To lower the SARS-CoV-2 nosocomial infection, all health care professionals should wear protective goggles.The inefficient diagnostic method and the sampling time lag may contribute to the lower positive rate of conjunctival swab samples of SARS-CoV-2.","Ocul Surf","Zhang, Xian","Chen, Xuhui","Chen, Liwen","Deng, Chaohua","Zou, Xiaojing","Liu, Weiyong","Yu, Huimin","Chen, Bo","Sun, Xufang","32289466"],"abstract":["This is a cross-sectional study of patients who received a COVID-19 diagnosis between December 30, 2019 and February 7, 2020 at Tongji Hospital. A total of 102 patients (48 Male [47%] and 54 Female [53%]) with clinical symptoms, Rt, and chest Computed Tomography (CT) abnormalities were identified with a clinical diagnosis of COVID-19. Patients had a mean [SD] gestational age of 57.63 [14.90] years. Of a total of 102 patients identified, 72 patients (36 men [50%] and 36 women [50%]; mean [SD] age, 58.68 [14.81] years) were confirmed to have COVID-19 by laboratory diagnosis with a SARS-CoV-2 RT-PCR assay. Only two patients (2.78%) with conjunctivitis were identified from 72 patients with a laboratory confirmed COVID-19. Of those two patients, SARS-CoV-2 RNA fragments were found in ocular discharges by SARS-CoV-2 RT-PCR in only one patient. Our findings suspect the incidence of SARS-CoV-2 infection through the ocular surface is extremely low, while the nosocomial infection of SARS-CoV-2 through the eyes after occupational exposure is a potential route. To lower the SARS-CoV-2 nosocomial infection, all health care professionals should wear protective goggles.The inefficient diagnostic method and the sampling time lag may contribute to the lower positive rate of conjunctival swab samples of SARS-CoV-2."],"journal":"Ocul Surf","authors":["Zhang, Xian","Chen, Xuhui","Chen, Liwen","Deng, Chaohua","Zou, Xiaojing","Liu, Weiyong","Yu, Huimin","Chen, Bo","Sun, Xufang"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289466","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jtos.2020.03.010","keywords":["covid-19","conjunctival swab","ocularsurface","reverse-transcriptase-polymerase-chain-reaction","sars-cov-2","transmission route"],"topics":["Transmission","Prevention","Diagnosis"],"weight":1,"_version_":1666138491323416577,"score":64.41259},{"pmid":32436625,"title":"Low risk of SARS-CoV-2 transmission through the ocular surface.","text":["Low risk of SARS-CoV-2 transmission through the ocular surface.","Acta Ophthalmol","Deng, Chaohua","Yang, Yang","Chen, Huawen","Chen, Wei","Chen, Zhiqi","Ma, Ke","Wang, Junming","32436625"],"journal":"Acta Ophthalmol","authors":["Deng, Chaohua","Yang, Yang","Chen, Huawen","Chen, Wei","Chen, Zhiqi","Ma, Ke","Wang, Junming"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436625","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/aos.14471","topics":["Transmission","Prevention"],"weight":1,"_version_":1667521393815715840,"score":60.73745},{"pmid":32035510,"pmcid":"PMC7133551","title":"2019-nCoV transmission through the ocular surface must not be ignored.","text":["2019-nCoV transmission through the ocular surface must not be ignored.","Lancet","Lu, Cheng-Wei","Liu, Xiu-Fen","Jia, Zhi-Fang","32035510"],"journal":"Lancet","authors":["Lu, Cheng-Wei","Liu, Xiu-Fen","Jia, Zhi-Fang"],"date":"2020-02-10T11:00:00Z","year":2020,"_id":"32035510","source":"PubMed","week":"20207|Feb 10 - Feb 16","doi":"10.1016/S0140-6736(20)30313-5","link_comment_in":"32165057","link_comment_for":"31986264","topics":["Transmission"],"weight":1,"_version_":1666138493021061122,"score":60.624535},{"pmid":32461419,"title":"Commentary: Exploring the transmission of COVID-19 through the ocular surface.","text":["Commentary: Exploring the transmission of COVID-19 through the ocular surface.","Indian J Ophthalmol","Joseph, Joveeta","32461419"],"journal":"Indian J Ophthalmol","authors":["Joseph, Joveeta"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461419","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.4103/ijo.IJO_1493_20","link_comment_for":"32461418","topics":["Transmission","Prevention"],"weight":1,"_version_":1668079521483456514,"score":58.232338},{"pmid":32355863,"pmcid":"PMC7183451","title":"SARS-CoV-2 in the ocular surface of COVID-19 patients.","text":["SARS-CoV-2 in the ocular surface of COVID-19 patients.","The 2019 novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, while the routes of transmission of this virus are still controversial. We enrolled 33 patients, without any ocular manifestation, with their ocular surface swabs collected for virus detection. RNA was detected strong positive in samples of both eyes from two patients. Therefore, SARS-CoV-2 may exist in the normal ocular surface of COVID-19 patients, suggesting that this virus might be spread through conjunctival contact.","Eye Vis (Lond)","Xie, Hua-Tao","Jiang, Shi-Yun","Xu, Kang-Kang","Liu, Xin","Xu, Bing","Wang, Lin","Zhang, Ming-Chang","32355863"],"abstract":["The 2019 novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, while the routes of transmission of this virus are still controversial. We enrolled 33 patients, without any ocular manifestation, with their ocular surface swabs collected for virus detection. RNA was detected strong positive in samples of both eyes from two patients. Therefore, SARS-CoV-2 may exist in the normal ocular surface of COVID-19 patients, suggesting that this virus might be spread through conjunctival contact."],"journal":"Eye Vis (Lond)","authors":["Xie, Hua-Tao","Jiang, Shi-Yun","Xu, Kang-Kang","Liu, Xin","Xu, Bing","Wang, Lin","Zhang, Ming-Chang"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32355863","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1186/s40662-020-00189-0","keywords":["covid-19","ocular surface","sars-cov-2"],"topics":["Transmission"],"weight":1,"_version_":1666138495149670400,"score":56.05271}]}